Healthpeak Properties’ (DOC) Buy Rating Reaffirmed at Mizuho

Mizuho reissued their buy rating on shares of Healthpeak Properties (NYSE:DOC) in a research report report published on Monday, MarketBeat Ratings reports. They currently have a $22.00 price target on the real estate investment trust’s stock.

A number of other research analysts also recently weighed in on DOC. StockNews.com upgraded shares of Healthpeak Properties from a sell rating to a hold rating in a research report on Friday, April 5th. Compass Point decreased their price objective on shares of Healthpeak Properties from $19.00 to $18.00 and set a buy rating for the company in a research report on Tuesday, January 2nd. Wells Fargo & Company assumed coverage on shares of Healthpeak Properties in a research report on Monday, March 25th. They issued an equal weight rating and a $19.00 price objective for the company. KeyCorp reissued a sector weight rating on shares of Healthpeak Properties in a research note on Friday, January 5th. Finally, Bank of America raised shares of Healthpeak Properties from an underperform rating to a buy rating and boosted their target price for the stock from $18.00 to $25.00 in a research note on Monday, April 1st. Six analysts have rated the stock with a hold rating and five have given a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of Hold and an average price target of $18.10.

Healthpeak Properties Trading Up 1.4 %

NYSE DOC opened at $18.23 on Monday. The company has a fifty day moving average of $16.10 and a 200 day moving average of $13.57. The company has a market capitalization of $12.93 billion, a PE ratio of 32.54, a P/E/G ratio of 1.77 and a beta of 1.02. Healthpeak Properties has a 1 year low of $15.24 and a 1 year high of $22.38. The company has a debt-to-equity ratio of 1.00, a current ratio of 0.67 and a quick ratio of 0.67.

Institutional Trading of Healthpeak Properties

Several large investors have recently bought and sold shares of DOC. Norges Bank purchased a new stake in Healthpeak Properties during the 4th quarter valued at about $34,883,000. Leeward Investments LLC MA purchased a new stake in Healthpeak Properties during the 4th quarter valued at about $13,038,000. abrdn plc grew its stake in Healthpeak Properties by 1,749.1% during the 4th quarter. abrdn plc now owns 919,351 shares of the real estate investment trust’s stock valued at $12,237,000 after acquiring an additional 869,631 shares in the last quarter. Angelo Gordon & CO. L.P. purchased a new stake in Healthpeak Properties during the 4th quarter valued at about $3,713,000. Finally, Charles Schwab Investment Management Inc. grew its stake in Healthpeak Properties by 6.5% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 3,943,465 shares of the real estate investment trust’s stock valued at $52,488,000 after acquiring an additional 239,972 shares in the last quarter. Hedge funds and other institutional investors own 93.57% of the company’s stock.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.